改善药品获取及其他方面:中国国家基于数量的采购政策
Zheng Zhu1, Quan Wang1,2, Qiang Sun3
1Department of Health Policy and Management, Peking University School of Public Health, Beijing, China.
BMJ global health
|July 18, 2023
概括
中国的国家量化采购 (NVBP) 集中购买药品,以降低价格和改善获取. 该政策平衡了降低成本与制药行业的可持续性.
科学领域:
- 卫生政策 卫生政策
- 制药经济学 制药经济学
- 公共卫生 公共卫生
背景情况:
- 中国中央政府于2019年启动了聚合采购系统,以集中国家购买力.
- 这导致了制药行业实施国家基于数量采购 (NVBP) 政策.
研究的目的:
- 提供对中国国家基于数量采购 (NVBP) 政策的深入分析.
- 检查NVBP的目标,特点,挑战和影响.
- 了解政策对药物价格,药物可用性和制药行业的影响.
主要方法:
- 对NVBP政策进行深入分析.
- 检查关键特征:集中采购,以数量为基础的方法,保证数量.
- 对中国的合并采购与其他方法进行比较分析.
- 评估挑战和影响,包括行业影响和降价可持续性.
主要成果:
- 该NVBP政策的特点是一个集中式系统,以量为基础的采购和成功投标人的保证量.
- 分析涉及政策对制药行业动态的影响以及实现的降价可持续性.
- 对比的见解突出显示了中国采购策略的独特特点.
结论:
- 该NVBP旨在降低药品价格,并提高在中国获得负担得起的药物的机会.
- 将降低价格与制药行业的可持续性相平衡,对于政策的长期成功至关重要.
- 该NVBP代表了一项独特的倡议,对中国的医疗保健政策和实践具有重大潜在影响.
关键词:
卫生政策 卫生政策相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
186
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
186
Prescription, Nonprescription and Orphan Drugs
768
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
768
International Nursing Organizations II
1.0K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.0K
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Drug Distribution: Volume of Distribution
5.2K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
5.2K
Volume of Distribution
241
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
241


